AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline OPHC Q1 2026 Earnings EPS Misses Estimates by 1475 MCFT Q1 2026 Earnings EPS Surges Past Estimates DUK Q1 2026 Earnings Modest EPS Beat Drives Positive Market Reaction TNXP Q1 2026 Earnings WiderthanExpected Loss Amid Continued RD Investment C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue